Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:19 pm Purchase | 2023-12-31 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | SUVRETTA CAPITAL MANAGEMENT LLC | 2,684,005 7.800% | 887,626![]() (+49.41%) | Filing History |
| 2024-02-13 5:16 pm Purchase | 2023-12-31 | 13G | BENITEC BIOPHARMA INC BNTC | SUVRETTA CAPITAL MANAGEMENT LLC | 262,843 9.990% | 85,183![]() (+47.95%) | Filing History |
| 2024-02-13 5:08 pm Purchase | 2023-12-31 | 13G | BIOHAVEN RESH LTD. USD COM SHS BHVN | SUVRETTA CAPITAL MANAGEMENT LLC | 4,572,836 5.700% | 723,898![]() (+18.81%) | Filing History |
| 2024-02-13 12:29 pm Sale | 2023-12-31 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | SUVRETTA CAPITAL MANAGEMENT LLC | 9,534,837 9.990% | -57,375![]() (-0.60%) | Filing History |
| 2024-02-13 12:24 pm Purchase | 2023-12-31 | 13G | 89BIO INC ETNB | SUVRETTA CAPITAL MANAGEMENT LLC | 4,888,434 5.200% | 80,060![]() (+1.67%) | Filing History |
| 2024-02-13 12:16 pm Purchase | 2023-12-31 | 13G | SUTRO BIOPHARMA INC STRO | SUVRETTA CAPITAL MANAGEMENT LLC | 577,819 9.500% | 21,309![]() (+3.83%) | Filing History |
| 2024-02-13 12:13 pm Purchase | 2023-12-31 | 13G | MARINUS PHARMACEUTICALS INC MRNS | SUVRETTA CAPITAL MANAGEMENT LLC | 5,463,641 9.990% | 491,981![]() (+9.90%) | Filing History |
| 2024-02-13 12:08 pm Purchase | 2023-12-31 | 13G | FULCRUM THERAPEUTICS INC FULC | SUVRETTA CAPITAL MANAGEMENT LLC | 5,518,881 8.900% | 1,244,078![]() (+29.10%) | Filing History |
| 2024-02-13 12:00 pm Purchase | 2023-12-31 | 13G | EYEPOINT INC EYPT | SUVRETTA CAPITAL MANAGEMENT LLC | 4,774,389 9.990% | 1,363,179![]() (+39.96%) | Filing History |
| 2024-02-13 11:55 am Purchase | 2023-12-31 | 13G | KEZAR LIFE SCIENCES INC KZR | SUVRETTA CAPITAL MANAGEMENT LLC | 716,759 9.900% | 366,333![]() (+104.54%) | Filing History |
| 2024-02-13 11:50 am Purchase | 2023-12-31 | 13G | ARCELLX INC ACLX | SUVRETTA CAPITAL MANAGEMENT LLC | 2,435,974 5.000% | 85,641![]() (+3.64%) | Filing History |
| 2024-02-13 11:44 am Purchase | 2023-12-31 | 13G | TERNS PHARMACEUTICALS INC TERN | SUVRETTA CAPITAL MANAGEMENT LLC | 5,837,126 9.500% | 2,388,851![]() (+69.28%) | Filing History |
| 2024-02-05 4:43 pm Purchase | 2024-01-26 | 13G | COGENT BIOSCIENCES INC COGT | SUVRETTA CAPITAL MANAGEMENT LLC | 5,481,034 6.400% | 5,481,034![]() (New Position) | Filing History |
| 2023-10-30 5:03 pm Purchase | 2023-10-20 | 13G | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | SUVRETTA CAPITAL MANAGEMENT LLC | 9,592,212 9.990% | 9,592,212![]() (New Position) | Filing History |
| 2023-10-30 5:02 pm Purchase | 2023-10-18 | 13G | 89BIO INC ETNB | SUVRETTA CAPITAL MANAGEMENT LLC | 4,808,374 6.400% | 4,808,374![]() (New Position) | Filing History |
| 2023-06-15 4:31 pm Purchase | 2023-06-05 | 13G | ZURA BIO LTD ZURA | SUVRETTA CAPITAL MANAGEMENT LLC | 2,850,000 6.600% | 2,850,000![]() (New Position) | Filing History |
| 2023-04-24 4:47 pm Purchase | 2023-04-12 | 13G | INFLARX N V COM IFRX | SUVRETTA CAPITAL MANAGEMENT LLC | 5,733,910 10.300% | 3,587,670![]() (+167.16%) | Filing History |
| 2023-04-18 4:16 pm Sale | 2022-12-31 | 13G | BENITEC BIOPHARMA INC BNTC | SUVRETTA CAPITAL MANAGEMENT LLC | 177,660 9.990% | -194,616![]() (-52.28%) | Filing History |
| 2023-03-10 5:15 pm Purchase | 2023-01-25 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | SUVRETTA CAPITAL MANAGEMENT LLC | 1,796,379 5.300% | 724,077![]() (+67.53%) | Filing History |
| 2023-02-13 4:37 pm Purchase | 2022-12-31 | 13G | PROKIDNEY CORP PROK | SUVRETTA CAPITAL MANAGEMENT LLC | 6,280,175 10.200% | 10,875![]() (+0.17%) | Filing History |

